Dr. Arnfin Bergmann MD, CEO of NeuroTransData GmbH, had the opportunity to introduce the AI-PROGNOSIS project during conversations with participants at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders.

Although not part of the official program, the project gained visibility among international experts attending one of the most prominent events in the field of neurodegenerative disorders. The AD/PD 2025 conference gathered researchers, clinicians, and industry leaders to explore the latest breakthroughs in treatment, translational research, early diagnosis, drug development, and clinical trials in Alzheimer’s, Parkinson’s, and related neurological conditions.

Participation at such events strengthens the network and visibility of the AI-PROGNOSIS initiative, supporting its mission to bring AI-driven innovation to early diagnosis and personalised treatment in neurology.